Fruth Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$569K Hold
23,650
0.14% 139
2026
Q1
$664K Sell
23,650
-1,112
-4% -$29.6K 0.17% 129
2025
Q4
$616K Sell
24,762
-1,000
-4% -$25.2K 0.17% 130
2025
Q3
$656K Sell
25,762
-1,761
-6% -$43.5K 0.18% 121
2025
Q2
$667K Sell
27,523
-400
-1% -$9.33K 0.18% 122
2025
Q1
$707K Sell
27,923
-550
-2% -$14.4K 0.2% 117
2024
Q4
$755K Sell
28,473
-625
-2% -$17K 0.21% 109
2024
Q3
$842K Sell
29,098
-500
-2% -$14.6K 0.22% 105
2024
Q2
$828K Hold
29,598
0.23% 104
2024
Q1
$821K Buy
29,598
+2,000
+7% +$55.5K 0.21% 113
2023
Q4
$794K Sell
27,598
-900
-3% -$27.2K 0.22% 107
2023
Q3
$945K Sell
28,498
-425
-1% -$15K 0.28% 97
2023
Q2
$1.06M Sell
28,923
-100
-0.3% -$3.89K 0.3% 92
2023
Q1
$1.18M Hold
29,023
0.34% 87
2022
Q4
$1.49M Sell
29,023
-382
-1% -$18.3K 0.44% 73
2022
Q3
$1.29M Sell
29,405
-44
-0.1% -$2.14K 0.43% 77
2022
Q2
$1.54M Buy
29,449
+161
+0.5% +$8.2K 0.42% 77
2022
Q1
$1.52M Sell
29,288
-25
-0.1% -$1.3K 0.42% 77
2021
Q4
$1.73M Buy
29,313
+200
+0.7% +$9.91K 0.47% 64
2021
Q3
$1.25M Sell
29,113
-200
-0.7% -$8.86K 0.39% 78
2021
Q2
$1.15M Buy
29,313
+785
+3% +$30.5K 0.34% 86
2021
Q1
$1.03M Sell
28,528
-110
-0.4% -$3.91K 0.32% 90
2020
Q4
$1.05M Sell
28,638
-1,125
-4% -$41.3K 0.37% 80
2020
Q3
$1.04M Buy
29,763
+15,916
+115% +$558K 0.41% 72
2020
Q2
$429K Hold
13,847
0.18% 119
2020
Q1
$428K Sell
13,847
-33
-0.2% -$1.12K 0.22% 110
2019
Q4
$515K Buy
13,880
+105
+0.8% +$3.74K 0.2% 118
2019
Q3
$469K Sell
13,775
-369
-3% -$13.4K 0.19% 119
2019
Q2
$581K Sell
14,144
-52
-0.4% -$2.06K 0.23% 110
2019
Q1
$572K Sell
14,196
-1,033
-7% -$41.4K 0.24% 112
2018
Q4
$630K Sell
15,229
-633
-4% -$26.3K 0.3% 104
2018
Q3
$663K Buy
15,862
+422
+3% +$16.2K 0.27% 107
2018
Q2
$531K Sell
15,440
-275
-2% -$9.4K 0.23% 113
2018
Q1
$529K Sell
15,715
-106
-0.7% -$3.64K 0.23% 115
2017
Q4
$543K Sell
15,821
-210
-1% -$7.16K 0.23% 116
2017
Q3
$542K Sell
16,031
-106
-0.7% -$3.41K 0.25% 109
2017
Q2
$514K Buy
16,137
+205
+1% +$6.46K 0.24% 111
2017
Q1
$517K Sell
15,932
-527
-3% -$16.6K 0.24% 112
2016
Q4
$507K Sell
16,459
-106
-0.6% -$3.24K 0.23% 112
2016
Q3
$532K Sell
16,565
-421
-2% -$14.1K 0.26% 105
2016
Q2
$567K Buy
16,986
+611
+4% +$19.5K 0.27% 104
2016
Q1
$460K Sell
16,375
-211
-1% -$6.03K 0.23% 113
2015
Q4
$507K Hold
16,586
0.26% 108
2015
Q3
$494K Buy
16,586
+295
+2% +$9.46K 0.26% 108
2015
Q2
$518K Sell
16,291
-2,213
-12% -$72.1K 0.24% 116
2015
Q1
$610K Sell
18,504
-214
-1% -$6.8K 0.26% 110
2014
Q4
$553K Sell
18,718
-657
-3% -$18.8K 0.23% 123
2014
Q3
$543K Buy
19,375
+3,248
+20% +$91.2K 0.24% 124
2014
Q2
$466K Sell
16,127
-369
-2% -$10.5K 0.21% 133
2014
Q1
$482K Hold
16,496
0.23% 124
2013
Q4
$479K Hold
16,496
0.23% 124
2013
Q3
$449K Buy
16,496
+893
+6% +$24.3K 0.24% 120
2013
Q2
$414K Buy
+15,603
New +$431K 0.23% 123

Other funds holding PFE

Fruth Investment Management's PFE Position: Q2 2026 in Review

Fruth Investment Management held its Pfizer (PFE) position steady in Q2 2026 at 23,650 shares worth $569K. The position accounts for 0.14% of the portfolio, ranked #139.

Fruth Investment Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.73M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Fruth Investment Management held 23,650 shares of Pfizer worth $569K as of Q2 2026.
  • Fruth Investment Management left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.14% of Fruth Investment Management's portfolio in Q2 2026, its #139 holding.
  • Fruth Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Fruth Investment Management's Pfizer position peaked at $1.73M in Q4 2021.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Fruth Investment Management's 13F filing for Q2 2026, filed 10 Jul 2026.